全球药品安全依靠强有力的国家体系，这种体系监测药物的开发和质量，对危害作用做出报告，并对药物的安全使用提供准确信息。
Global drug safety depends on strong national systems that monitor the development and quality of medicines, report their harmful effects, and provide accurate information for their safe use.
EPCIS规范允许使用关于供应链中的标记药品的上下文信息增强来自原始读事件的信息。
The EPCIS specification permits the data from raw read events to be augmented with contextual information about the observation of tagged items in the supply chain.
对人类染色体的测序、新工具和新技术的诞生加速了基因组学信息的使用，在药品研发方面开创了新途径。
The use of genomic information, accelerated by the sequencing of the human genome and the advent of new tools and technologies, has opened new possibilities in drug discovery and development.
获得了病人用药档案的制药企业可能利用这些信息向病人施加压力，迫使病人使用其生产的药品。
Drug companies with access to pharmaceutical records might try to pressure patients to switch to their products.
获得了病人用药档案的制药企业可能利用这些信息向病人施加压力，迫使病人使用其生产的药品。
Drug companies with access to pharmaceutical records might try to pressure patients to switch to their products.
应用推荐